CanSino Biologics Inc. (BST:CJH)
Germany flag Germany · Delayed Price · Currency is EUR
3.460
0.00 (0.00%)
At close: Apr 28, 2026

CanSino Biologics Statistics

Total Valuation

BST:CJH has a market cap or net worth of EUR 1.41 billion. The enterprise value is 1.24 billion.

Market Cap 1.41B
Enterprise Value 1.24B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date Mar 30, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 132.67M
Shares Outstanding n/a
Shares Change (YoY) +2.32%
Shares Change (QoQ) +59.67%
Owned by Insiders (%) 31.07%
Owned by Institutions (%) 8.01%
Float 159.89M

Valuation Ratios

The trailing PE ratio is 414.20 and the forward PE ratio is 33.36.

PE Ratio 414.20
Forward PE 33.36
PS Ratio 10.81
PB Ratio 2.33
P/TBV Ratio 2.42
P/FCF Ratio n/a
P/OCF Ratio 126.89
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 124.60, with an EV/FCF ratio of -66.67.

EV / Earnings 365.78
EV / Sales 9.59
EV / EBITDA 124.60
EV / EBIT n/a
EV / FCF -66.67

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.26.

Current Ratio 3.67
Quick Ratio 3.32
Debt / Equity 0.26
Debt / EBITDA 15.68
Debt / FCF -8.43
Interest Coverage -2.22

Financial Efficiency

Return on equity (ROE) is 0.57% and return on invested capital (ROIC) is -2.45%.

Return on Equity (ROE) 0.57%
Return on Assets (ROA) -0.72%
Return on Invested Capital (ROIC) -2.45%
Return on Capital Employed (ROCE) -1.43%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 114,672
Profits Per Employee 2,993
Employee Count 1,134
Asset Turnover 0.14
Inventory Turnover 0.84

Taxes

Income Tax -746,982
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.50% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -13.50%
50-Day Moving Average 3.59
200-Day Moving Average 4.46
Relative Strength Index (RSI) 42.33
Average Volume (20 Days) 60

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BST:CJH had revenue of EUR 130.04 million and earned 3.39 million in profits. Earnings per share was 0.01.

Revenue 130.04M
Gross Profit 97.93M
Operating Income -10.69M
Pretax Income 2.65M
Net Income 3.39M
EBITDA 9.32M
EBIT -10.69M
Earnings Per Share (EPS) 0.01

Balance Sheet

The company has 321.93 million in cash and 156.90 million in debt, giving a net cash position of 165.02 million.

Cash & Cash Equivalents 321.93M
Total Debt 156.90M
Net Cash 165.02M
Net Cash Per Share n/a
Equity (Book Value) 603.20M
Book Value Per Share 2.44
Working Capital 340.20M

Cash Flow

In the last 12 months, operating cash flow was 11.08 million and capital expenditures -29.70 million, giving a free cash flow of -18.62 million.

Operating Cash Flow 11.08M
Capital Expenditures -29.70M
Depreciation & Amortization 20.52M
Net Borrowing -90.15M
Free Cash Flow -18.62M
FCF Per Share n/a

Margins

Gross margin is 75.31%, with operating and profit margins of -8.22% and 2.61%.

Gross Margin 75.31%
Operating Margin -8.22%
Pretax Margin 2.04%
Profit Margin 2.61%
EBITDA Margin 7.17%
EBIT Margin -8.22%
FCF Margin n/a

Dividends & Yields

BST:CJH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 159.68%
Buyback Yield -2.32%
Shareholder Yield -2.32%
Earnings Yield 0.24%
FCF Yield -1.32%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BST:CJH has an Altman Z-Score of 3.82 and a Piotroski F-Score of 7.

Altman Z-Score 3.82
Piotroski F-Score 7